Endocrine Abstracts

Introduction: The number of individuals seeking gender-affirming hormonal treatment (GAHT), as well as the ratio between transgender men and transgender women, has increased over the past two decades. The type of GAHT varies significantly among different countries due to differences in availability and reimbursement policies. We aimed to analyze the kinds of GAHT and demographic characteristics of transgender adults at our endocrine clinic, the only center caring for transgend...

Introduction: Hypercalcemia is mostly caused by primary hyperparathyroidism and malignancy. Parathyromatosis is a rare condition characterized by multiple nodules of hyperfunctioning parathyroid tissue scattered throughout the neck and superior mediastinum, which can present a diagnostic and therapeutic challenge.Case report: A 56-year-old woman visited the ER due to chest pain, left-sided neck edema, and hematoma. The day before, she experienced left-si...

Introduction: Antiresorptive treatment can preserve bone mineral density (BMD) in patients with primary hyperparathyroidism (PHPT) when surgery is not feasible or desired. We aimed to compare the impact of zoledronate vs denosumab on bone-related biochemical parameters in this population.Methods: We analyzed preliminary data from our ongoing randomized trial on osteoporotic postmenopausal women with PHPT who are being treated either with zoledronate 5 mg...